Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-15T19:20:56.820Z Has data issue: false hasContentIssue false
  • English
  • Français

Maternal and neonatal characteristics of a Canadian urban cohort receiving treatment for opioid use disorder during pregnancy

Part of: A Canadian perspective on DOHaD

Published online by Cambridge University Press:  16 August 2018

C. Miller Open the ORCID record for C. Miller [Opens in a new window] ,
D. Grynspan ,
L. Gaudet ,
E. Ferretti ,
S. Lawrence ,
F. Moretti ,
A. Lafreniere ,
A. McGee ,
S. Lattuca  and
A. Black
C. Miller
Affiliation:
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
D. Grynspan
Affiliation:
Department of Pathology and Laboratory Medicine, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
L. Gaudet
Affiliation:
Department of Obstetrics and Gynecology, School of Epidemiology, Public Health and Preventive Medicine, Ottawa Hospital, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada
E. Ferretti
Affiliation:
Department of Pediatrics, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada Department of Pediatrics, Division of Neonatology, Ottawa Hospital, Ottawa, Ontario, Canada Department of Pediatrics, Division of Neonatology, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
S. Lawrence
Affiliation:
Department of Pediatrics, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
F. Moretti
Affiliation:
Department of Obstetrics and Gynecology, Ottawa Hospital, Ottawa, Ontario, Canada Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada
A. Lafreniere
Affiliation:
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada Department of Pathology and Laboratory Medicine, Ottawa Hospital, Ottawa, Ontario, Canada
A. McGee
Affiliation:
Department of Obstetrics and Gynecology, Ottawa Hospital, Ottawa, Ontario, Canada
S. Lattuca
Affiliation:
Department of Obstetrics and Gynecology, Ottawa Hospital, Ottawa, Ontario, Canada
A. Black
Affiliation:
Department of Obstetrics and Gynecology, Ottawa Hospital, Ottawa, Ontario, Canada Obstetrics and Gynecology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Get access Rights & Permissions [Opens in a new window]

Abstract

The epidemic of prescription and non-prescription opioid misuse is of particular importance in pregnancy. The Society of Obstetricians and Gynaecologists of Canada currently recommends opioid replacement therapy with methadone or buprenorphine for opioid-dependent women during pregnancy. This vulnerable segment of the population has been shown to be at increased risk of blood-borne infectious diseases, nutritional insecurity and stress. The objective of this study was to describe an urban cohort of pregnant women on opioid replacement therapy and to evaluate potential effects on the fetus. A retrospective chart review of all women on opioid replacement therapy and their infants who delivered at The Ottawa Hospital General and Civic campuses between January 1, 2013 and March 24, 2017 was conducted. Data were collected on maternal characteristics, pregnancy outcomes, neonatal outcomes and corresponding placental pathology. Maternal comorbidities identified included high rates of infection, tobacco use and illicit substance use, as well as increased rates of placental abruption compared with national averages. Compared with national baseline averages, the mean neonatal birth weight was low, and the incidence of small for gestational age infants and congenital anomalies was high. The incidence of NAS was comparable with estimates from other studies of similar cohorts. Findings support existing literature that calls for a comprehensive interdisciplinary risk reduction approach including dietary, social, domestic, psychological and other supports to care for opioid-dependent women in pregnancy.

Keywords

neonateopioidplacentapregnancy
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 10 , Special Issue 1: Themed Issue: Canada / Indigenous Populations , February 2019 , pp. 132 - 137
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. United Nations Office on Drug and Crime. World Drug Report, 2016. United Nations Publication: New York.Google Scholar
2. Public Health Ontario. Opioid-related morbidity and mortality in Ontario. 2017. Retrieved 5 September 2017 from https://www.publichealthontario.ca/en/dataandanalytics/pages/opioid.aspx.Google Scholar
3. Brogly, SB, et al. Infants born to opioid-dependent women in Ontario, 2002-2014. J Obset Gynaecol Can. 2017; 39, 157–165.Google Scholar
4. Jumah, NA, Edwards, C, Balfour-Boehm, J, et al. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ. 2016; 6, 1–8.Google Scholar
5. SOGC Clinical Practice Guidelines. Substance use in pregnancy. Int J Gynecol Obstet. 2011; 256, 190–202.Google Scholar
6. Kandall, SR, Albin, S, Gartner, LM, et al. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev. 1977; 1, 159e69.Google Scholar
7. Wilson, GS, Desmond, MM, Wait, RB. Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr. 1981; 98, 716–722.Google Scholar
8. Jones, HE, Martin, PR, Heil, SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Substance Abuse Treat. 2008; 35, 245–259.Google Scholar
9. Pond, SM, Kreek, MJ, Tong, TG, Raghunath, J, Benowitz, NL. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther. 1985; 233, 1–6.Google Scholar
10. Filteau, J, Coo, H, Dow, K. Trends in incidence of neonatal abstinence syndrome and associated healthcare utilization. Drug Alcohol Dependence. 2018; 185, 313–321.Google Scholar
11. Jones, HE, Kaltenbach, K, Heil, SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363, 2320–2331.Google Scholar
12. Domenici, C, Cuttano, A, Nardini, V, et al. Drug addiction during pregnancy: correlations between the placental health and the newborn’s outcome – elaboration of a predictive score. Gynecol Endocrinol. 2009; 12, 786–792.Google Scholar
13. Serra, AE, Lemon, LS, Mokhtari, NB, et al. Delayed villous maturation in term placentas exposed to opioid maintanence therapy: a retrospective cohort study. Am J Obstet Gynecol. 2017; 216, 418e1–418e5.Google Scholar
14. Unger, A, Metz, V, Fischer, G. Opioid dependent and pregnant: what are the best options for mothers and neonates. Obstet Gynecol Int. 2012; 2012, 195954.Google Scholar
15. Magee, LA, Helewa, M, Rey, E, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014; 36, 416–438.Google Scholar
16. Royal College of Obstetricians and Gynaecologists UK, Green-top Guideline No. 31: the Investigation and Management of the Small-for Gestational-age Fetus, 2013.Google Scholar
17. Hudak, ML, Tan, RC, Committee on Drugs, Committee on Fetus and Newborn. Neonatal drug withdrawal. Pediatrics. 2012; 129(2), e540–e560.Google Scholar
18. Khong, TY, Mooney, EE, Ariel, I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016; 140, 698–713.X2.Google Scholar
19. Ananth, CV, Keyes, KM, Hamilton, A, et al. An international contrast of rates of placental abruption: an age-period-cohort analysis. PLoS One. 2015; 10, e0125246.Google Scholar
20. Ruiter, L, Ravelli, AC, de Graaf, IM, et al. Incidence and recurrence rate of placental abruption: a longitudinal linked natioanl cohort study in the Netherlands. Am J Obstet Gynceol. 2015; 213, 573.e1–8.Google Scholar
21. Hoskins, IA, Friedman, DM, Frieden, FJ, et al. Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption. Obset Gynecol. 1991; 78, 279.Google Scholar
22. Suzuki, K, Minei, LJ, Johnson, EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980; 136, 1009.Google Scholar
23. Kaminsky, LM, Ananth, CV, Prasad, V, et al. The influence of maternal cigarette smoking on placental pathology in pregnancies complicated by abruption. Am J Obstet Gynecol. 2007; 197, 275.e1.Google Scholar
24. Leone, JM, Lane, SD, Koumans, EH, et al. Effects of intimate partner violence on pregnancy trauma and placental abruption. J Women’s Health. 2010; 19, 1501–1509.Google Scholar
25. Statistics Canada, Canadian Vital Statistics, Birth Database. CANSIM table 102-4317.Google Scholar
26. Toal, M, Chan, C, Fallah, S, et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol. 2007; 196, 363.e1–363.e7.Google Scholar
27. Pijnenborg, R, Vercruysse, L, Hanssens, M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006; 27, 939–958.Google Scholar
28. Harper, PS. Practical Genetic Counselling, 5th edition, 1998. Butterworth Heinemann: Boston, 56–70.Google Scholar
29. Broussard, CS, Rasmussen, SA, Reefhuis, J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011; 204, 314.e1–314.e11.Google Scholar
30. Shrestha, S, Jiminez, E, Garrison, L, et al. Dietary intake among opioid- and alcohol-using pregnant women. Subst Use Misuse. 2017; 1–10.Google Scholar
31. Tomedi, LE, Bogen, DL, Hanusa, BH, et al. A pilot study of the nutritional status of opiate-using pregnant women on methadone maintanence therapy. Subst Use Misuse. 2012; 47, 286–295.Google Scholar
32. Himmelgreen, DA, Perez-Escamilla, R, Segura-Millan, S. A comparison of the nutritional status and food security of drug-using and non-drug-using Hispanic women in Hartford, Connecticut. Am J Phys Anthropol. 1998; 107, 351–361.Google Scholar
33. Zador, D, Lyons Wall, PM, Webseter, I. High sugar intake in a group of women on methadone maintanence in South Western Sydney, Australia. Addiction. 1996; 91, 1053–1061.Google Scholar
34. Cheschier, N. ACOG committee on practice bulletins-obstetrics. ACOG practice bulletin. Neural tube defects. Number 44, July 2003 (Replaces committee opinion number 252, March 2001). Int J Gynecol Obstet. 2003; 83: 123–133.Google Scholar
35. Statistics Canada. Canadian Vital Statistics, Birth Database. CANSIM table 102-4510.Google Scholar
36. Statistics Canada. Preterm live births in Canada, 2000–2013. October 26, 2016.Google Scholar
37. Lee, HS. Impact of maternal diet on the epigenome during in utero life and the developmental programming of diseases in childhood and adulthood. Nutrients. 2015; 7, 9492–9507.Google Scholar
38. Claycombe, KJ, Brissette, CA, Ghribi, O. Epigenetics of inflammation, maternal infection, and nutrition. J Nutr. 2015; 145, 1109S–1115S.Google Scholar
39. Palma-Gudiel, H, Cordova-Palomera, A, Eixarch, E, et al. Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring: a meta-analysis. Epigenetics. 2015; 10, 893–902.Google Scholar
40. Wallack, L, Thornburg, K. Developmental origins, epigenetics, and equity: moving upstream. Matern Child Health J. 2016; 20, 935–940.Google Scholar